lino Biotech AG
Miltenyi Biotec acquired lino Biotech in March 2023. As part of Miltenyi Biotec, lino Biotech produces biosensor platforms for focal molography, used for biomolecular interaction analysis (BIA) with applications in bioprocessing, drug screening, diagnostics, and cell and gene therapy.
Facts and figures
Focus
Biomolecular interaction analysis
Location
Zurich, Switzerland
Number of employees
~10
General information
lino Biotech develops and manufactures focal molography platforms. Focal molography is a nanotechnology-based method combining photolithography, surface chemistry, and state-of-the-art optical technologies.
Expertise and technology
Focal molography provides data to characterize biological interactions in living cells or crude biological samples. The company’s expertise in surface chemistry, biological functionalization, and lithographic fabrication processes allows them to tackle cutting-edge sensor fabrication challenges at a high level. lino Biotech has developed unique knowledge in generating sub-micron biomolecular assemblies, providing opportunities to explore new possibilities in sensor technology. Affiliation with the Miltenyi Group offers promising synergies in establishing new standards for biomolecular interaction analysis.
Milestones
- 2011 – First patent filed by Hoffmann-LaRoche on general principle of focal molography
- 2014 – Collaborative research started with ETH Zurich
- 2020 – lino Biotech founded
- 2023 – Miltenyi Biotec acquires lino Biotech
Open positions
Explore new job opportunities in the Miltenyi Group
lino Biotech AG
Soodstrasse 52, 8134 Adliswil, Zurich, Switzerland
info@lino-biotech.com
You have previously chosen International as your location.
What do you want to do?